Preoperative administration of propranolol reduced the surgical risks of PHACES syndrome in a 14-month-old girl

Yuka Rokugo, Chiharu Ota, Masato Kimura, Yoji Sasahara

研究成果: Article査読

抄録

PHACES syndrome is an uncommon neurocutaneous disorder first identified in 1996. Patients with PHACES syndrome often require surgical treatment for their anomalies, including intracranial vasculopathy, coarctation/interruption of the aorta, intracardiac defects, glaucoma/cataract and sternal defects. Risk factors associated with the symptoms of intraoperative/perioperative management include ischaemic stroke due to the cerebral vasculopathy, airway obstruction due to the subglottic/tracheal haemangiomas and massive bleeding due to the large haemangiomas. Recently, propranolol is considered as first-line therapy for patients with infantile haemangiomas (IHs). However, until now, there have been no reported cases of PHACES syndrome treated by propranolol to reduce the surgical risks associated with IH. In this report, we describe a case of a 14-month-old Japanese girl with PHACES syndrome treated by propranolol for IH before surgical closure of the ventricular septum defect. Oral administration of propranolol was effective in decreasing the size of IH, leading to the uneventful perioperative course.

本文言語English
論文番号e228117
ジャーナルBMJ case reports
12
4
DOI
出版ステータスPublished - 2019 4 1

ASJC Scopus subject areas

  • 医学(全般)

フィンガープリント

「Preoperative administration of propranolol reduced the surgical risks of PHACES syndrome in a 14-month-old girl」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル